Evidence map›Paper›PMID 32708917›Full record

ArticleCells2020

Regulation of Neurogenesis in Mouse Brain by HMGB1.

Xiang Zhao, Ari Rouhiainen, Zhilin Li, Su Guo, Heikki Rauvala

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. HMGB1-Induced Neurite Outgrowth in the Dorsal Root Ganglion Neurons and Regeneration Priming after their Axonal Injury by Sciatic Nerve Crush.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xiang ZhaoDepartment of Bioengineering and Therapeutic Sciences, Programs in Human Genetics and Biological Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, CA 94143-2811, USA.ORCID 0000-0002-3339-4806
Ari RouhiainenHelsinki Institute of Life Science/Neuroscience Center, Biomedicum 1, P. O. Box 63 (Haartmaninkatu 8), University of Helsinki, FI-00014 Helsinki, Finland.
Zhilin LiHelsinki Institute of Life Science/Neuroscience Center, Biomedicum 1, P. O. Box 63 (Haartmaninkatu 8), University of Helsinki, FI-00014 Helsinki, Finland.ORCID 0000-0003-2867-2848
Su GuoDepartment of Bioengineering and Therapeutic Sciences, Programs in Human Genetics and Biological Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, CA 94143-2811, USA.
Heikki RauvalaHelsinki Institute of Life Science/Neuroscience Center, Biomedicum 1, P. O. Box 63 (Haartmaninkatu 8), University of Helsinki, FI-00014 Helsinki, Finland.
University of Helsinki · FIUniversity of California, San Francisco · US

Funding

Asymmetric Cell Division in Vertebrate Brain DevelopmentR01NS095734 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUO, SU · 2015 to 2019
$1.7M
NINDS NIH HHS R01 NS095734
6 · The paper itself

Abstract

The High Mobility Group Box 1 (HMGB1) is the most abundant nuclear nonhistone protein that is involved in transcription regulation. In addition, HMGB1 has previously been found as an extracellularly acting protein enhancing neurite outgrowth in cultured neurons. Although HMGB1 is widely expressed in the developing central nervous system of vertebrates and invertebrates, its function in the developing mouse brain is poorly understood. Here, we have analyzed developmental defects of the HMGB1 null mouse forebrain, and further examined our findings in ex vivo brain cell cultures. We find that HMGB1 is required for the proliferation and differentiation of neuronal stem cells/progenitor cells. Enhanced apoptosis is also found in the neuronal cells lacking HMGB1. Moreover, HMGB1 depletion disrupts Wnt/β-catenin signaling and the expression of transcription factors in the developing cortex, including Foxg1, Tbr2, Emx2, and Lhx6. Finally, HMGB1 null mice display aberrant expression of CXCL12/CXCR4 and reduced RAGE signaling. In conclusion, HMGB1 plays a critical role in mammalian neurogenesis and brain development.

Indexed as

NeurogenesisAnimalsApoptosisBrainCell ProliferationCells, CulturedChemokine CXCL12Down-RegulationEmbryo, MammalianHMGB1 ProteinMice, Inbred C57BLMice, KnockoutMorphogenesisNeural Stem CellsNeuronsReceptors, CXCR4Chemokine CXCL12HMGB1 ProteinReceptors, CXCR4Transcription Factorsbrain developmentCXCL12CXCR4differentiationHMGB1neurogenesis

Identifiers

PMID32708917
PMCPMC7407245
OpenAlexW3042680768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.